These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11157895)

  • 61. The judicious use of antibiotic agents in common childhood respiratory illness.
    Manning ML; Bell LM
    Nurs Clin North Am; 2000 Mar; 35(1):87-94. PubMed ID: 10673566
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax Tablet 200 mg), a quinolone antimicrobial].
    Tsuda H
    Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):111-8. PubMed ID: 18689961
    [No Abstract]   [Full Text] [Related]  

  • 63. Relevance of antibiotic tissue penetration in treating respiratory tract infections.
    Kneer J
    Respiration; 1993; 60 Suppl 1():32-7. PubMed ID: 8480088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
    Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
    Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
    Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL
    Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Future of antibiotic therapy in various medical fields. 1. Internal medicine. b. Respiratory tract infections].
    Hara K; Suzuyama Y
    Nihon Rinsho; 1984 Mar; 42(3):566-72. PubMed ID: 6381797
    [No Abstract]   [Full Text] [Related]  

  • 68. Judicious use of antibiotics to treat respiratory tract infections.
    File TM
    Curr Opin Infect Dis; 2002 Apr; 15(2):149-50. PubMed ID: 11964915
    [No Abstract]   [Full Text] [Related]  

  • 69. Microbiology and antimicrobial management of head and neck infections in children.
    Brook I
    Adv Pediatr; 2008; 55():305-25. PubMed ID: 19048735
    [No Abstract]   [Full Text] [Related]  

  • 70. The hidden impact of antibacterial resistance in respiratory tract infection. Steering an appropriate course: principles to guide antibiotic choice.
    Cars O
    Respir Med; 2001 Jun; 95 Suppl A():S20-5; discussion S26-7. PubMed ID: 11419671
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Will we still have antibiotics tomorrow?].
    Dronda SB; Justribó MV
    Arch Bronconeumol; 2007 Aug; 43(8):450-9. PubMed ID: 17692246
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Introduction: antimicrobial resistance among pediatric respiratory tract and nosocomial pathogens.
    Dowell SF
    Semin Pediatr Infect Dis; 2004 Jan; 15(1):3-4. PubMed ID: 15175990
    [No Abstract]   [Full Text] [Related]  

  • 73. Newer antibiotics for the treatment of respiratory tract infections.
    Blasi F; Tarsia P; Cosentini R; Valenti V
    Curr Opin Pulm Med; 2004 May; 10(3):189-96. PubMed ID: 15071370
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Respiratory infections and antimicrobial therapy.
    Alford BR
    Arch Otolaryngol; 1969 Jul; 90(1):112-4. PubMed ID: 5785982
    [No Abstract]   [Full Text] [Related]  

  • 75. The false dichotomy of viral versus bacterial aetiology in upper respiratory tract infections.
    Davis JS; Magin PJ; van Driel ML
    Med J Aust; 2019 Aug; 211(3):108-109.e1. PubMed ID: 31232463
    [No Abstract]   [Full Text] [Related]  

  • 76. The need for antimicrobial resistance surveillance.
    Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():1-7. PubMed ID: 12239224
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Therapeutic strategies in respiratory infections in children].
    Cohen R; Reinert P
    Arch Pediatr; 1996; 3 Suppl 1():101s-104s. PubMed ID: 8795979
    [No Abstract]   [Full Text] [Related]  

  • 78. The use of antibiotics in pulmonary infections.
    Yourassowsky E
    Acta Clin Belg; 1981; 36(4):213-6. PubMed ID: 7315127
    [No Abstract]   [Full Text] [Related]  

  • 79. Respiratory infections and antimicrobial therapy.
    Saunders WH
    Arch Otolaryngol; 1966 Sep; 84(3):359-61. PubMed ID: 5946821
    [No Abstract]   [Full Text] [Related]  

  • 80. Maximizing outcomes in respiratory tract infections in the age of resistance.
    Nicolau DP
    Pharmacotherapy; 2002 Jan; 22(1 Pt 2):1S; discussion 30S-32S. PubMed ID: 11791626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.